Brainstorm Cell Therapeutics | BCLI - Pre Tax Profit


Brainstorm Cell Therapeutics reported $-2.86M in Pre-Tax Profit for its fiscal quarter ending in March of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Biogen USD 557.3M 186.7M Sep/2025
Brainstorm Cell Therapeutics USD -2.86M 109K Mar/2025
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -6.94M 421K Sep/2025
CSL USD 2.61B 1.21B Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Grifols EUR 66.98M 19.92M Jun/2024
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Mesoblast USD -54.09M 6.37M Jun/2025